Related Experiment Video
Updated: Jul 12, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Nasal CPAP in the Pediatric Ward to Reduce PICU Admissions for Severe Bronchiolitis?
Melodie O Aricò1, Diana Wrona2, Giovanni Lavezzo2
1Department of Pediatrics, G.B. Morgagni-L. Pierantoni Hospital, AUSL Romagna, 48018 Forli, Italy.
Insights
Continuous positive airway pressure (CPAP) for infant bronchiolitis can be safely managed on a general pediatric ward. This approach reduces pediatric intensive care unit (PICU) admissions during outbreaks.
Area of Science:
- Pediatrics
- Respiratory Medicine
Background:
- Acute bronchiolitis in infants frequently necessitates transfer to a pediatric intensive care unit (PICU) for continuous positive airway pressure (CPAP) therapy.
- Managing CPAP in a general pediatric ward can alleviate PICU strain during bronchiolitis outbreaks.
Purpose of the Study:
- To evaluate the feasibility and safety of managing infants with bronchiolitis using CPAP in a general pediatric ward.
- To assess the impact of ward-based CPAP on PICU admission rates.
Main Methods:
- Retrospective collection of clinical data from infants under 12 months admitted for bronchiolitis between October 2021 and March 2023.
- Comparison of outcomes between infants treated with nasal CPAP (nCPAP) in the general ward and those receiving other oxygen support methods or no support.
Main Results:
- Out of 82 infants, 16 received nCPAP, with only 3 (19%) requiring PICU transfer due to clinical deterioration.
- The majority of infants (50%) did not require oxygen support, while others received low-flow or high-flow nasal cannulas.
- No infants with coinfection (RSV/SARS-CoV-2) or SARS-CoV-2 infection required oxygen support.
Conclusions:
- Nasal CPAP therapy for infant bronchiolitis can be safely and effectively administered in a general pediatric ward setting.
- Implementing ward-based CPAP can significantly reduce the need for PICU admissions, optimizing resource allocation.
- Successful implementation requires comprehensive staff training, vigilant patient monitoring, and strong collaboration with the PICU.
Abstract:
In treating acute bronchiolitis in infants, the decision to use continuous positive airway pressure (CPAP) often involves infant referral from the pediatric ward to the pediatric intensive care unit (PICU). We present our experience of CPAP use in a general pediatric ward, aiming to reduce the pressure on the PICU in recent outbreaks of bronchiolitis. Clinical data of patients less than 12 months of age and admitted for bronchiolitis from 1 October 2021 to 31 March 2023 were retrospectively collected. Of 82 infants admitted for bronchiolitis, 16 (19%) were treated with nasal CPAP (nCPAP group); of the remaining 66, 21 (26%) were treated with a low-flow nasal cannula (LFNC) only, 1 (1%) was also treated a with high-flow nasal cannula (HFNC), 12 (15%) were treated with an HFNC only, and 41 (50%) were treated without oxygen support (no-nCPAP group). Overall, coinfection with RSV and SARS-CoV-2 was observed in three patients and SARS-CoV-2 infection was observed in two patients. None of them required any type of oxygen support. Only 3/16 (19%) infants in the nCPAP group were referred to the PICU due to worsening clinical conditions despite nCPAP support. In our experience of treating epidemic bronchiolitis, nCPAP can be safely managed in a general pediatric ward, thus reducing the burden of admissions to the PICU. Training and regular updating of the pediatric staff, careful monitoring of the patient, and close cooperation with the PICU were instrumental for our team.
Related Concept Videos
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Administering Oxygen by Nasal Cannula
Nasal Cannulas
A nasal cannula is a lightweight tube split into two prongs placed in the nostrils,...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Suctioning the Nasopharyngeal Airway
Equipment Required
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
COPD: Management Using Bronchodilators and Corticosteroids

